W A de Boer
Overview
Explore the profile of W A de Boer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
553
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Limperg P, Haverman L, Beijlevelt M, van der Pot M, Zaal G, de Boer W, et al.
Haemophilia
. 2017 Mar;
23(3):362-369.
PMID: 28321962
Introduction: Children growing up with haemophilia are at greater risk for psychosocial problems than their healthy peers. Providing psychosocial care to children with haemophilia and their families is indispensable, since...
2.
Tangerman A, Winkel E, de Laat L, van Oijen A, de Boer W
J Breath Res
. 2012 Feb;
6(1):017102.
PMID: 22368251
There is disagreement about a possible relationship between Helicobacter pylori (H. pylori) infection and objective halitosis, as established by volatile sulfur compounds (VSCs) in the breath. Many studies related to...
3.
Seven-day PPI-triple therapy with levofloxacin is very effective for Helicobacter pylori eradication
Schrauwen R, Janssen M, de Boer W
Neth J Med
. 2009 Mar;
67(3):96-101.
PMID: 19307680
Background: Helicobacter pylori infection causes lifelong gastritis and is associated with the development of peptic ulcer disease, MALT lymphoma and gastric cancer. Many patients benefit from H. pylori eradication therapy....
4.
van Keeken N, van Hattum E, de Boer W
Neth J Med
. 2006 Oct;
64(9):329-33.
PMID: 17057270
Background: To compare the accuracy and reaction time of a new dry rapid urease test (GUT test) with the CLO test and an independent gold standard in the diagnosis of...
5.
Janssen M, Hendrikse L, de Boer S, Bosboom R, de Boer W, Laheij R, et al.
Neth J Med
. 2006 Jun;
64(6):191-5.
PMID: 16788217
Aim: Most patients treated for H. pylori infection receive empirical therapy based on epidemiological data of antibiotic resistance. However, previous European studies indicate that resistance patterns may be changing. Therefore,...
6.
Janssen M, Schneeberger P, de Boer W, Laheij R, J B M J Jansen
Ned Tijdschr Geneeskd
. 2005 Oct;
149(39):2175-7.
PMID: 16223077
Objective: To measure the prevalence of metronidazole- or clarithromycin-resistant Helicobacter pylori. DESIGN. Retrospective. Method: All positive H. pylori cultures with known susceptibility to metronidazole or clarithromycin between 1998 and 2003...
7.
van IJzendoorn M, Laheij R, de Boer W, J B M J Jansen
Neth J Med
. 2005 May;
63(4):141-5.
PMID: 15869042
Background: The aim of this study was to determine whether an antral biopsy alone represents an adequate tissue sample to diagnose the presence of Helicobacter pylori on the mucosa. Furthermore,...
8.
Janssen M, Laheij R, de Boer W, J B M J Jansen
Aliment Pharmacol Ther
. 2005 Feb;
21(4):341-5.
PMID: 15709984
Background: There is much debate about the influence of pre-treatment with a proton pump inhibitor on Helicobacter pylori eradication. The few studies investigating the influence of pre-treatment on triple and...
9.
Janssen M, Laheij R, J B M J Jansen , de Boer W
Neth J Med
. 2004 Oct;
62(6):192-6.
PMID: 15460498
Background: Many patients treated for H. pylori infection have been taking a proton pump inhibitor beforehand. There is conflicting evidence whether pretreatment influences the efficacy of H. pylori eradication. The...
10.
de Boer W, Kuipers E, Kusters J
Dig Liver Dis
. 2004 Jun;
36(5):311-4.
PMID: 15191198
No abstract available.